• Trials and Research

  Kesimpta Offers Safety, Efficacy, Flexibility to Relapsing MS, Experts Say

  Posted by MS News Today Moderator on September 10, 2020 at 9:36 am

  

  Click here to read an interview between a Novartis scientist and a neurologist in which they discuss Kesimpta’ efficacy and safety, and the convience of once monthly at-home use.

  What did you think of this interview?

  MS News Today Moderator replied 5 years, 5 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply